Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Hepato-Gastroenterology|July 8, 2009
Plasma level of granulocyte-colony stimulating factor during granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitisHiroaki Takeda, Shoichi Nishise, Tadahisa Fukui, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 2, 2006
Detection of Legionella pneumophila serogroup 7 strain from bathwater samples in a Japanese hospitalShigeru Fujimura, Tomohiro Oka, Osamu Tooi, et al.
Internal Medicine (Tokyo, Japan)|June 19, 2013
Relapsing polychondritis complicated by giant cell myocarditis and myositisMari Watanabe, Hiroki Suzuki, Tomoka Ara, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2010
Release of interleukin-1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatinShoichi Nishise, Yuji Takeda, Shoichiro Fujishima, et al.
Clinical Neurology and Neurosurgery|August 23, 2025
Focal electroencephalography abnormality in the early stage of sporadic Creutzfeldt-Jakob disease corresponding to neuroradiological findings: A magnetoencephalography experienceHiroaki Takeda, Shogo Yazawa, Takashi Murahara, et al.
World Journal of Gastroenterology|March 12, 2010
Decreased levels of plasma adiponectin associated with increased risk of colorectal cancerSayaka Otake, Hiroaki Takeda, Shoichiro Fujishima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 11, 2012
Production of interleukin-10 by combining a granulocyte and monocyte adsorption carrier with ulinastatinShoichi Nishise, Takeshi Sato, Yu Sasaki, et al.
NPJ Cardiovascular Health|March 3, 2026
Characterizing lipoprotein profiles in coronary atherosclerosis development through quantitative lipidomics and proteomics approachesHiroaki Takeda, Yoshihiro Izumi, Yui Koike, et al.
Cancer Research|November 6, 2014
Four-in-one antibodies have superior cancer inhibitory activity against EGFR, HER2, HER3, and VEGF through disruption of HER/MET crosstalkShi Hu, Wenyan Fu, Weihao Xu, et al.
Amino Acids|March 17, 2015
Structure-based development and optimization of therapy antibody drugs against TNFαWenyan Fu, Xiaoze Wang, Weili Yang, et al.
Pageof 11